Company news

Enanta Pharmaceuticals, Inc. news in 2020

Enanta Pharmaceuticals, Inc.'s news releases, calls and decks from 2020, newest first.

View company

Enanta Pharmaceuticals Announces the Appointment of Tara L. Kieffer, Ph.D. as Senior Vice President, New Product Strategy and Development

December 7, 2020

Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year Ended September 30, 2020

November 22, 2020

Enanta Pharmaceuticals to Host Conference Call on November 23 at 4: 30 p.m. ET to Discuss its Financial Results for its Fiscal Fourth Quarter and Year Ended September 30, 2020

November 15, 2020

Enanta Pharmaceuticals Initiates Phase 1 Clinical Study of EDP-297, its Highly Potent and Targeted Follow-On Farnesoid X Receptor Agonist for the Treatment of Non-Alcoholic Steatohepatitis

September 13, 2020

Enanta Pharmaceuticals Announces Data Presentations at the European Association for the Study of the Liver (EASL) Digital International Liver Congress™ 2020

August 19, 2020

Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter Ended June 30, 2020 with Webcast and Conference Call Today at 4: 30 p.m. ET

August 3, 2020

Enanta Pharmaceuticals to Host Conference Call on August 4 at 4: 30 p.m. ET to Discuss its Financial Results for its Fiscal Third Quarter Ended June 30, 2020

July 27, 2020

Enanta Pharmaceuticals Announces Clinical Trial Progress for EDP-514, its Lead Core Inhibitor for Hepatitis B Virus

July 8, 2020

Enanta Pharmaceuticals Announces the Appointment of Mark G. Foletta to Its Board of Directors

June 28, 2020

Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2020 with Webcast and Conference Call Today at 4: 30 p.m. ET

May 5, 2020

Enanta Announces Results of INTREPID Study of EDP-305 for the Treatment of Primary Biliary Cholangitis

May 5, 2020

Enanta Provides Update on Clinical Development Activities During COVID-19 Pandemic

March 25, 2020

Enanta Pharmaceuticals Announces Efforts to Discover a Treatment for the Novel Coronavirus Disease COVID-19

March 12, 2020

Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter and Three Months Ended December 31, 2019

February 5, 2020

Enanta to Host Conference Call on February 6 at 4: 30 p.m. ET to Discuss Financial Results for its Fiscal First Quarter Ended December 31, 2019

January 23, 2020

Calls in 2020

Decks in 2020